Results 101 to 110 of about 1,213 (150)

Effects of Switching From Another Sodium-Glucose Cotransporter 2 Inhibitor to Tofogliflozin on Nocturia in Patients With Type 2 Diabetes. [PDF]

Cureus
Inoue S, Yasuda H, Yoshida K, Mori K, Ogawa K, Yokotsuka Y, Okamoto H.   +6 more
europepmc   +1 more source

Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin?

Archives of Medical Science – Atherosclerotic Diseases, 2018
openaire   +2 more sources

Effects of antidiabetic drugs on the level of serum uric acid in patients who have type 2 diabetes. [PDF]

Saudi Med J
Wang G, Wang G.
europepmc   +1 more source

Gender Bias in Clinical Trials of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Systematic Review. [PDF]

J Diabetes Res
Lora-Escobar SJ, Rodríguez-de Francisco L, López-Feijoo M, Santos-Ramos B, Bellido V, Casado-Mejía R, Acosta-García H.   +6 more
europepmc   +1 more source

Impact of Sodium-Glucose Co-Transporter 2 Inhibitors on Atrial Fibrillation Recurrence Post-Catheter Ablation Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. [PDF]

J Cardiovasc Electrophysiol
Abdelhadi NA, Ragab KM, Elkholy M, Koneru J, Ellenbogen KA, Pillai A.   +5 more
europepmc   +1 more source

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Ahmed AE, Alhufayyan NS, Qadri HF, Atiah AF, Alhazmi WM, Alhazemi NT, Zalah HA, Nasser FM, Monajid RM, Aljuhani MG.   +9 more
europepmc   +1 more source

Effectiveness of SGLT2 inhibitors compared to sulphonylureas for long-term glycemic control in type 2 diabetes: A meta-analysis. [PDF]

Biomol Biomed
Zhan Z, Wang J, Shen N, Liu X, Wang L.
europepmc   +1 more source

Effect of Tofogliflozin on Cardiac Function: Potential Link Between Ketone Bodies and the Heart

Journal of Endocrinology and Metabolism, 2017
openaire   +2 more sources

Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated by Diabetes: Pathophysiology and Emerging Therapies. [PDF]

J Obes Metab Syndr
Goto H, Takamura T.
europepmc   +1 more source

Increasing Prescription of SGLT2 Inhibitors with Expanded Indications to the Elderly Population in Japan. [PDF]

Kidney Dis (Basel)
Oda Y, Nishi H, Sekiguchi M, Odawara M, Nangaku M.   +4 more
europepmc   +1 more source